Viewing Study NCT00320359


Ignite Creation Date: 2025-12-24 @ 2:35 PM
Ignite Modification Date: 2026-01-29 @ 11:00 AM
Study NCT ID: NCT00320359
Status: COMPLETED
Last Update Posted: 2017-03-01
First Post: 2006-05-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line Extensive Disease Small Cell Lung Cancer
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Cancer, Small Cell View
Keywords:

Keywords

Keyword Brief Keyword Text View
None First-line Cisplatin View
None Small Cell Lung Cancer View
None topotecan View
None etoposide View
None Extensive Disease View